Hangzhou Tigermed Consulting Co., Ltd
HNGZY
$3.96
-$0.1386-3.38%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 215.04M | 195.52M | 247.52M | 225.85M | 231.25M |
| Total Other Revenue | -- | 17.94M | -8.74M | 8.64M | -- |
| Total Revenue | 215.04M | 213.46M | 238.78M | 234.49M | 231.25M |
| Cost of Revenue | 150.46M | 175.37M | 149.76M | 137.14M | 143.76M |
| Gross Profit | 64.58M | 38.09M | 89.01M | 97.34M | 87.49M |
| SG&A Expenses | 33.03M | 31.47M | 32.75M | 38.55M | 32.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -808.30K | -25.90K | 1.59M | 2.58M | -1.07M |
| Total Operating Expenses | 190.81M | 216.03M | 190.73M | 186.66M | 184.21M |
| Operating Income | 24.24M | -2.57M | 48.05M | 47.82M | 47.04M |
| Income Before Tax | 19.75M | -58.75M | 55.45M | 45.26M | 50.47M |
| Income Tax Expenses | 4.63M | 4.55M | 7.18M | 11.42M | 6.94M |
| Earnings from Continuing Operations | 15.12M | -63.29M | 48.27M | 33.83M | 43.54M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 7.63M | 6.54M | -3.49M | 1.76M | -10.79M |
| Net Income | 22.75M | -56.76M | 44.78M | 35.60M | 32.74M |
| EBIT | 24.24M | -2.57M | 48.05M | 47.82M | 47.04M |
| EBITDA | 31.29M | 4.56M | 54.51M | 54.81M | 53.48M |
| EPS Basic | 0.03 | -0.07 | 0.05 | 0.04 | 0.04 |
| Normalized Basic EPS | 0.03 | 0.01 | 0.03 | 0.04 | 0.02 |
| EPS Diluted | 0.03 | -0.07 | 0.05 | 0.04 | 0.04 |
| Normalized Diluted EPS | 0.03 | 0.01 | 0.03 | 0.04 | 0.02 |
| Average Basic Shares Outstanding | 870.89M | 856.11M | 866.76M | 858.66M | 870.64M |
| Average Diluted Shares Outstanding | 870.89M | 856.11M | 866.76M | 858.66M | 870.64M |
| Dividend Per Share | -- | 0.04 | -- | -- | -- |
| Payout Ratio | 16.35% | -8.16% | 169.91% | 13.15% | 12.87% |